查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442616

首頁 分子測試市場：按產品類型、最終用戶、地區、規模、份額、成長、趨勢、預測 2023-2030 年進行的全球產業分析

At-Home Molecular Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 221 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近對家庭分子檢測市場進行了深入分析，並提供了全球狀況的綜合報告。該報告提供了有關市場動態、趨勢、機會和挑戰的重要見解，並詳細概述了市場結構。該研究報告預測了 2023 年至 2030 年家庭分子檢測市場的預期成長軌跡，並提供了獨特的數據和統計數據。

家庭分子檢測市場預計將以 6.0% 的複合年增長率穩定成長。預計到 2030 年，這一數字將從 2023 年的 109 億美元增加到 163 億美元。

  • 重要見解

首頁 分子檢測市場規模（2023年）：美國：109億美元

預測市場規模（2030F）：163億美元

全球市場成長率（2023-2030年複合年增長率）：6.0%

過去的市場成長率（2018-2022年複合年增長率）：5.7%

首頁 分子檢測市場-調查範圍

家庭分子檢測市場正在迅速擴大，提供了個人可以在家中進行的便利分子診斷檢測。這些測試通常分析遺傳物質，例如 DNA 或 RNA，並提供對健康各個方面的深入瞭解，例如家庭關係、某些疾病的潛在風險和遺傳傾向。這種創新的診斷方法使個人能夠透過提供易於使用且方便的測試解決方案，採取積極主動的措施來管理自己的健康。持續的技術進步正在簡化分子測試並降低成本，推動家庭分子測試市場的顯著成長。

幾個關鍵因素正在推動全球家庭分子檢測產業的顯著擴張。首先，人們對個人化醫療的認識和興趣不斷增強，推動了對基因檢測服務的需求，這些服務可以對個人健康狀況進行量身定制的分析。消費者越來越多地尋求遺傳訊息，以便就預防措施、生活方式選擇和潛在的醫療幹預措施做出明智的決定。此外，分子生物學方法的進步和易於使用的測試工具的可用性簡化了家庭分析所需的樣本收集和提交過程。這種增加的便利性吸引了更廣泛的用戶群，並在市場成長中發揮至關重要的作用。

  • 市場成長動力

對個人化醫療不斷增長的需求是全球家庭分子檢測市場擴張的主要動力。這種形式的測試在個人化醫療保健的發展中發揮著重要作用，個人化醫療保健正在轉向根據個人的基因譜量身定制醫療干預措施。個人化醫療的核心是相信醫療保健應根據每個患者獨特的基因組成進行客製化。隨著人們對瞭解個人遺傳傾向的潛在好處的認識不斷增強，對家庭分子檢測的需求也相應增加。推動這種需求的是對主動健康管理的渴望。

在當今的醫療保健環境中，患者尋求的不是被動治療，而是主動管理健康的知識。個人化醫療之所以有吸引力，是因為它可以識別個體對某些疾病的易感性，並允許人們根據遺傳傾向採取預防措施或調整生活習慣。家庭分子檢測透過為個人提供一種方便且易於使用的方法來分析其基因組成而無需訪問臨床機構，從而促進了這種主動方法。基因研究的進步發現了許多與多種健康狀況相關的遺傳標記，包括遺傳疾病和與生活方式相關的疾病傾向。

  • 市場限制因素

全球家庭分子檢測市場面臨的關鍵挑戰之一是確保在臨床環境之外獲得的結果的準確性和可靠性。家庭測試因其易於使用且易於使用而廣受歡迎，但樣本收集過程中缺乏專業監督引發了人們對潛在不準確和不一致的擔憂。與傳統實驗室環境（由訓練有素的專業人員監督樣本採集）不同，DIY 測試會帶來無意變化的風險，從而影響結果的準確性。在根據這些結果做出診斷和健康相關決策時，這一點尤其重要。適應監管環境並遵守嚴格的監管要求以確保檢測服務的品質和可靠性已成為全球家庭分子檢測市場的關鍵挑戰。

隨著家庭分子檢測變得越來越普遍，監管機構面臨著跟上技術進步的步伐同時保護消費者利益的複雜挑戰。從健康傾向評估到譜系分析等各種可用的測試使監管環境變得更加複雜。平衡促進創新和消費者保護需要採取細緻的方法。我們面臨的挑戰是制定全面的法規，有效管理家庭檢測，解決其獨特的特徵，確保結果的準確性，保護資料隱私，並最大限度地減少潛在的健康風險。這是為了抑制它。

  • 機會

機器學習（ML）和人工智慧（AI）技術的快速融合正在推動全球家庭分子檢測市場向前發展。將先進的計算工具融入分子診斷有可能徹底改變家庭測試，提供提高效率、準確性和個人化見解的機會。隨著家庭分子測試產生的遺傳數據量的增加，機器學習和人工智慧演算法將在發現重要模式和相關性以及將原始數據轉化為可行的見解方面發揮關鍵作用。

人工智慧和機器學習的融合將徹底改變遺傳數據分析，使人們能夠更全面地瞭解個人的健康狀況。這些技術可以檢測傳統分析方法遺漏的微妙模式和關係，並且可以以超出人類能力的速度和規模分析海量資料集。這不僅提高了診斷結果的準確性，也為更先進和個人化的健康建議鋪平了道路。人工智慧驅動的平台可以揭示複雜的遺傳交互作用，並提供對疾病風險和潛在治療反應的更深入見解。

本報告解決的關鍵問題

  • 目前全球家庭分子檢測市場的規模和成長率是多少？
  • 推動家庭分子檢測擴展的關鍵因素是什麼？
  • 個人化醫療將如何促進這個市場的成長？
  • 家庭測試結果的準確性和可靠性有哪些挑戰？
  • 哪些監管障礙和監管要求會影響家庭分子檢測市場？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
    • 主要趨勢
  • 產品生命週期分析
  • 首頁 分子檢測市場：價值鏈
    • 原材料供應商名單
    • 製造商名單
    • 經銷商名單
    • 應用清單
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 世界GDP成長率展望
    • 全球母公司市場概覽
  • 預測變量 - 相關性和影響
  • 監管和技術格局

第三章 全球家庭分子檢測市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
    • 市場容量（單位）預測
    • 市場規模及年成長率
    • 絕對的賺錢機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2013-2016
    • 目前市場規模預測，2018-2026
  • 全球家庭分子檢測市場展望：產品
    • 簡介/主要發現
    • 2018-2022 年依產品歷史市場規模（百萬美元）及銷售量（單位）分析
    • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
      • 卡式磁帶
      • 條
      • 測試板
      • 浸卡
      • 中產階級
      • 其他
  • 市場吸引力分析：產品
  • 全球家庭分子檢測市場前景：檢測類型
    • 簡介/主要發現
    • 2018年至2022年按測試類型劃分的歷史市場規模（百萬美元）和數量（單位）分析
    • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
      • 懷孕測試
      • 艾滋病毒檢測
      • 糖尿病
      • 感染
      • 葡萄糖測試
      • 排卵預測測試藥
      • 藥物濫用測試
      • 其他
  • 市場吸引力分析：測試型
  • 全球家庭分子檢測市場展望：樣本類型
    • 簡介/主要發現
    • 2018年至2022年歷史市場規模（百萬美元）和數量（單位）分析（按樣本類型）
    • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
      • 尿
      • 血液
      • 唾液
      • 其他
  • 市場吸引力分析：樣本類型
  • 全球家庭分子檢測市場前景：分銷管道
    • 簡介/主要發現
    • 2018-2022 年按分銷管道劃分的歷史市場規模（百萬美元）和銷售（單位）分析
    • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
      • 零售藥店
      • 藥店
      • 超市/大賣場
      • 網上藥店
  • 市場吸引力分析：分銷管道

第四章全球家庭分子檢測市場展望：地區

  • 主要亮點
  • 2018-2022 年按地區歷史市場規模（百萬美元）及成交量（單位）分析
  • 2023-2030 年按地區劃分的當前市場規模（百萬美元）和預測數量（單位）
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：區域

第五章北美家庭分子檢測市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年歷史市場規模（百萬美元）與市場銷售（單位）分析
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 美國
    • 加拿大
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 市場吸引力分析

第六章歐洲家庭分子檢測市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年按市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 按國家
    • 按產品
    • 按測試類型
    • 依樣品類型
    • 按分銷渠道
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 歐洲其他地區
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 市場吸引力分析

第七章東亞家庭分子檢測市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年按市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 按國家
    • 按產品
    • 按測試類型
    • 依樣品類型
    • 按分銷渠道
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 中國
    • 日本
    • 韓國
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 按測試類型預測的當前市場規模（百萬美元）和數量（單位）
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 市場吸引力分析

第八章南亞和大洋洲首頁分子檢測市場展望：過去（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年按市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 按國家
    • 按產品
    • 按測試類型
    • 依樣品類型
    • 按分銷渠道
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 印度
    • 東南亞
    • 紐西蘭
    • 南亞和大洋洲其他地區
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 市場吸引力分析

第九章拉丁美洲家庭分子檢測市場展望：過去（2018-2022）與預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年按市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 按國家
    • 按產品
    • 按測試類型
    • 依樣品類型
    • 按分銷渠道
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 市場吸引力分析

第10章中東和非洲首頁分子檢測市場展望：過去（2018-2022）和預測（2023-2030）

  • 主要亮點
  • 價格分析
  • 2018-2022 年按市場劃分的過往市場規模（百萬美元）和銷售量（單位）分析
    • 按國家
    • 按產品
    • 按測試類型
    • 依樣品類型
    • 按分銷渠道
  • 2023-2030 年各國目前市場規模（百萬美元）及銷售量（單位）預測
    • 海灣合作委員會
    • 埃及
    • 南非
    • 北非
    • 其他中東和非洲
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按測試類型劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 2023-2030 年按樣本類型劃分的當前市場規模（百萬美元）和預測數量（單位）
  • 2023-2030 年按分銷管道劃分的當前市場規模（百萬美元）和銷售（單位）預測
  • 市場吸引力分析

第十一章競爭格局

  • 2022 年市場份額分析
  • 市場結構
    • 按市場劃分的競爭強度圖
    • 比賽儀表板
    • 表觀產品容量
  • 公司簡介（詳細資訊 - 概述、財務、策略、近期發展）
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd
    • Sensing Self
    • PTE. Ltd
    • Atomo Diagnostics
    • Mankind Pharma

第十二章附錄

  • 調查方法
  • 調查假設
  • 縮寫
簡介目錄
Product Code: PMRREP33685

Persistence Market Research has recently conducted an in-depth analysis of the At-Home Molecular Testing Market, providing a comprehensive report on the global landscape. This report offers key insights into market dynamics, trends, opportunities, and challenges, offering a detailed overview of the market structure. The research publication presents exclusive data and statistics, projecting the anticipated growth trajectory of the At-Home Molecular Testing Market from 2023 to 2030.

The at-home molecular testing market is projected to grow steadily, with a compound annual growth rate (CAGR) of 6.0%. It is expected to rise from its 2023 value of US$10.9 billion to reach US$16.3 billion by the conclusion of 2030.

  • Key Insights:

At-home Molecular Testing Market Size (2023E): US$10.9 Bn

Projected Market Value (2030F): US$16.3 Bn

Global Market Growth Rate (CAGR 2023 to 2030): 6.0%

Historical Market Growth Rate (CAGR 2018 to 2022): 5.7%

At-Home Molecular Testing Market - Report Scope

The at-home molecular testing market is witnessing rapid expansion, offering convenient molecular diagnostic tests that individuals can perform from their homes. These tests typically involve analyzing genetic material like DNA or RNA, providing insights into various aspects of health such as familial relationships, potential risks for specific diseases, and genetic predispositions. This innovative approach to diagnostics empowers individuals to take proactive steps towards managing their health by offering accessible and convenient testing solutions. With continuous technological advancements streamlining and reducing the cost of molecular testing, the at-home molecular testing market is experiencing significant growth.

Several key factors are driving the substantial expansion of the global at-home molecular testing industry. Firstly, the increasing recognition and interest in personalized medicine have fueled demand for genetic testing services, which offer tailored analyses of individual health profiles. Consumers are increasingly seeking genetic information to make well-informed decisions about preventive measures, lifestyle choices, and potential medical interventions. Additionally, advancements in molecular biology techniques and the availability of user-friendly testing tools have simplified the process of sample collection and submission for home-based analysis. This enhanced convenience has played a pivotal role in market growth, appealing to a broader range of user demographics.

  • Market Growth Drivers

The escalating demand for personalized medication is a significant driving force behind the global market expansion of at-home molecular testing. This form of testing plays a crucial role in the evolving landscape of personalized healthcare, which has shifted towards tailoring medical interventions based on individual genetic profiles. Central to personalized medicine is the belief that healthcare should be customized to each patient's unique genetic makeup. As awareness grows about the potential benefits of understanding one's genetic predispositions, there's been a corresponding increase in the demand for at-home molecular testing. This demand is fueled by a desire for proactive health management.

In today's healthcare environment, patients seek more than reactive treatments; they want to be empowered with knowledge to proactively manage their health. Personalized medicine holds appeal because it identifies individual susceptibilities to specific diseases, empowering people to adopt preventive measures and make lifestyle adjustments based on their genetic predispositions. At-home molecular testing facilitates this proactive approach by providing individuals with a convenient and accessible means to analyze their genetic composition without needing to visit a clinical facility. Advancements in genetic research have led to the discovery of numerous genetic markers associated with a wide range of health conditions, including hereditary diseases and predispositions to lifestyle-related ailments.

  • Market Restraints

One significant challenge facing the global market for at-home molecular testing is ensuring the precision and reliability of outcomes obtained outside of clinical settings. While the accessibility and user-friendliness of at-home testing have led to its widespread adoption, the absence of expert supervision during sample collection raises concerns about potential inaccuracies and inconsistencies. Unlike traditional laboratory settings where trained professionals oversee sample collection, DIY testing introduces the risk of inadvertent variables that may compromise result accuracy. This becomes particularly critical when making diagnostic and health-related decisions based on these outcomes. To ensure the quality and reliability of testing services, navigating the regulatory landscape and adhering to stringent oversight requirements pose significant challenges for the global at-home molecular testing market.

The growing prevalence of at-home molecular testing presents regulatory bodies with the complex task of keeping pace with technological advancements while safeguarding consumer interests. The regulatory environment is further complicated by the diverse range of tests available, spanning health predisposition assessments to ancestry profiling. Striking a balance between fostering innovation and protecting consumers necessitates a nuanced approach. The challenge lies in developing comprehensive regulations that effectively govern at-home testing, addressing its unique characteristics, ensuring result accuracy, safeguarding data privacy, and minimizing potential health risks.

  • Opportunities

The rapid integration of machine learning (ML) and Artificial Intelligence (AI) technologies is propelling the global market for at-home molecular testing forward. This incorporation of advanced computational tools with molecular diagnostics holds the potential to revolutionize at-home testing, offering opportunities for enhanced efficiency, precision, and personalized insights. As the volume of genetic data generated through at-home molecular testing increases, ML and AI algorithms play a crucial role in uncovering significant patterns and correlations, transforming raw data into actionable insights.

The fusion of AI and machine learning brings about a fundamental shift in genetic data analysis, allowing for more comprehensive understanding of an individual's health profile. These technologies can detect subtle patterns and associations that traditional analytical methods may overlook, analyzing vast datasets at speeds and scales beyond human capacity. This not only enhances the accuracy of diagnostic results but also opens avenues for more advanced and personalized health recommendations. AI-powered platforms can unravel intricate genetic interactions, offering deeper insights into disease risks and potential treatment responses.

Key Questions Answered in Report::

  • What is the current size and growth rate of the global at-home molecular testing market?
  • What are the main factors driving the expansion of at-home molecular testing?
  • How does personalized medicine contribute to the growth of this market?
  • What challenges exist regarding the precision and reliability of at-home testing outcomes?
  • What regulatory hurdles and oversight requirements impact the at-home molecular testing market?

Competitive Intelligence and Business Strategy

Prominent players in the at-home molecular testing market, such as 23andMe, MyHeritage, and AncestryDNA, bolster and expand their market dominance through strategic initiatives. One crucial strategy involves diversifying testing services to meet a wide range of consumer needs. These companies offer comprehensive genetic testing products encompassing health-related insights, carrier status for specific conditions, disease susceptibilities, and ancestry research. By providing such a broad range of services, they not only attract a larger customer base but also foster customer loyalty by continually providing valuable insights. Moreover, robust branding and marketing strategies are vital for establishing and maintaining market leadership. These companies invest significantly in advertising campaigns to educate consumers about the benefits of at-home molecular testing. To make genetic testing more accessible to the general public, persuasive messaging often relies on celebrity endorsements, customer testimonials, and compelling narratives. Furthermore, strategic partnerships with pharmaceutical firms, healthcare providers, and research institutions are integral to their approach. By forming such alliances, these companies integrate their at-home molecular testing solutions into broader healthcare networks, potentially influencing medical interventions and treatment strategies informed by genetic information. This integration positions them as key players at the intersection of mainstream healthcare and genetic testing, while also expanding their market presence.

  • Key Companies Profiled
  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.
  • Nova Biomedical
  • AdvaCare Pharma
  • AccuBioTech Co., Ltd.
  • Atlas Medical UK

TaiDoc Technology Corporation

  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Sensing Self
  • PTE. Ltd
  • Atomo Diagnostics
  • Mankind Pharma

At-home Molecular Testing Market Segmentation

  • By Product:
  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others
  • By Test Type:
  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others
  • By Sample Type:
  • Urine
  • Blood
  • Saliva
  • Others
  • By Distribution Channel:
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • By Region:
  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Sample Type, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
    • 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations